Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
Is a |
Product containing betamethasone and calcipotriol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
Is a |
Product containing calcipotriol (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Betamethasone |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Vitamin D and/or vitamin D derivative |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Calcipotriol (substance) |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glucocorticoid hormone |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Some |
|
|
Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment |
Has manufactured dose form |
A semi-solid dose form consisting of a single-phase in which solids or liquids may be dissolved or dispersed in the base, which may be hydrophilic, hydrophobic or water-emulsifying. |
false |
Inferred relationship |
Some |
|
|